BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29132384)

  • 21. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer.
    Tan X; Fu Y; Chen L; Lee W; Lai Y; Rezaei K; Tabbara S; Latham P; Teal CB; Man YG; Siegel RS; Brem RF; Fu SW
    Oncotarget; 2016 Jan; 7(1):293-307. PubMed ID: 26588055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-409-3p regulates cell invasion and metastasis by targeting ZEB1 in breast cancer.
    Ma Z; Li Y; Xu J; Ren Q; Yao J; Tian X
    IUBMB Life; 2016 May; 68(5):394-402. PubMed ID: 27079864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-99a-5p suppresses breast cancer progression and cell-cycle pathway through downregulating CDC25A.
    Qin H; Liu W
    J Cell Physiol; 2019 Apr; 234(4):3526-3537. PubMed ID: 30443946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-204-5p inhibits proliferation and invasion and enhances chemotherapeutic sensitivity of colorectal cancer cells by downregulating RAB22A.
    Yin Y; Zhang B; Wang W; Fei B; Quan C; Zhang J; Song M; Bian Z; Wang Q; Ni S; Hu Y; Mao Y; Zhou L; Wang Y; Yu J; Du X; Hua D; Huang Z
    Clin Cancer Res; 2014 Dec; 20(23):6187-99. PubMed ID: 25294901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long non-coding RNA SNHG6 enhances cell proliferation, migration and invasion by regulating miR-26a-5p/MAPK6 in breast cancer.
    Lv P; Qiu X; Gu Y; Yang X; Xu X; Yang Y
    Biomed Pharmacother; 2019 Feb; 110():294-301. PubMed ID: 30522015
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hsa-miR-875-5p exerts tumor suppressor function through down-regulation of EGFR in colorectal carcinoma (CRC).
    Zhang T; Cai X; Li Q; Xue P; Chen Z; Dong X; Xue Y
    Oncotarget; 2016 Jul; 7(27):42225-42240. PubMed ID: 27302926
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Down-regulation of miR-199b-5p is correlated with poor prognosis for breast cancer patients.
    Fang C; Wang FB; Li Y; Zeng XT
    Biomed Pharmacother; 2016 Dec; 84():1189-1193. PubMed ID: 27788476
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. miR-493-5p attenuates the invasiveness and tumorigenicity in human breast cancer by targeting FUT4.
    Zhao L; Feng X; Song X; Zhou H; Zhao Y; Cheng L; Jia L
    Oncol Rep; 2016 Aug; 36(2):1007-15. PubMed ID: 27375041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
    Kong LY; Xue M; Zhang QC; Su CF
    Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-17-5p suppresses cell proliferation and invasion by targeting ETV1 in triple-negative breast cancer.
    Li J; Lai Y; Ma J; Liu Y; Bi J; Zhang L; Chen L; Yao C; Lv W; Chang G; Wang S; Ouyang M; Wang W
    BMC Cancer; 2017 Nov; 17(1):745. PubMed ID: 29126392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-138-5p contributes to cell proliferation and invasion by targeting Survivin in bladder cancer cells.
    Yang R; Liu M; Liang H; Guo S; Guo X; Yuan M; Lian H; Yan X; Zhang S; Chen X; Fang F; Guo H; Zhang C
    Mol Cancer; 2016 Dec; 15(1):82. PubMed ID: 27978829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-340 inhibits the migration, invasion, and metastasis of breast cancer cells by targeting Wnt pathway.
    Mohammadi-Yeganeh S; Paryan M; Arefian E; Vasei M; Ghanbarian H; Mahdian R; Karimipoor M; Soleimani M
    Tumour Biol; 2016 Jul; 37(7):8993-9000. PubMed ID: 26758430
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-150-5p regulates melanoma proliferation, invasion and metastasis via SIX1-mediated Warburg Effect.
    Yang X; Zhao H; Yang J; Ma Y; Liu Z; Li C; Wang T; Yan Z; Du N
    Biochem Biophys Res Commun; 2019 Jul; 515(1):85-91. PubMed ID: 31128917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of β3 integrin by miR-30a-5p modulates cell adhesion and invasion by interrupting Erk/Ets‑1 network in triple-negative breast cancer.
    Li W; Liu C; Zhao C; Zhai L; Lv S
    Int J Oncol; 2016 Mar; 48(3):1155-64. PubMed ID: 26781040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-181a-5p Inhibits Cancer Cell Migration and Angiogenesis via Downregulation of Matrix Metalloproteinase-14.
    Li Y; Kuscu C; Banach A; Zhang Q; Pulkoski-Gross A; Kim D; Liu J; Roth E; Li E; Shroyer KR; Denoya PI; Zhu X; Chen L; Cao J
    Cancer Res; 2015 Jul; 75(13):2674-85. PubMed ID: 25977338
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-142-5p Acts as a Significant Regulator Through Promoting Proliferation, Invasion, and Migration in Breast Cancer Modulated by Targeting SORBS1.
    Yu W; Li D; Zhang Y; Li C; Zhang C; Wang L
    Technol Cancer Res Treat; 2019; 18():1533033819892264. PubMed ID: 31789129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Down-Regulated miR-125a-5p Promotes the Reprogramming of Glucose Metabolism and Cell Malignancy by Increasing Levels of CD147 in Thyroid Cancer.
    Huang P; Mao LF; Zhang ZP; Lv WW; Feng XP; Liao HJ; Dong C; Kaluba B; Tang XF; Chang S
    Thyroid; 2018 May; 28(5):613-623. PubMed ID: 29634399
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-4732-5p promotes breast cancer progression by targeting TSPAN13.
    Wang YW; Zhao S; Yuan XY; Liu Y; Zhang K; Wang J; Zhu J; Ma R
    J Cell Mol Med; 2019 Apr; 23(4):2549-2557. PubMed ID: 30701690
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-485-5p suppresses breast cancer progression and chemosensitivity by targeting survivin.
    Wang M; Cai WR; Meng R; Chi JR; Li YR; Chen AX; Yu Y; Cao XC
    Biochem Biophys Res Commun; 2018 Jun; 501(1):48-54. PubMed ID: 29678577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.